Elanco Animal Health INC 10-Q quarterly reports

Elanco Animal Health Incorporated announced a 10% increase in Q2 2026 revenue to $1.37 billion and a significant rise in net income, driven by strong performance in its Pet Health and Farm Animal segments.

Elanco Animal Health Incorporated announced its first quarter 2026 financial results, showcasing a 15% increase in revenue and a net income of $57 million.

Elanco Animal Health reported a net loss of $34 million in Q3 2025, a significant decline from the prior year's profit, despite a 10% revenue increase driven by new product introductions.

Elanco Animal Health reported a significant turnaround in Q2 2025, achieving net income of $11 million compared to a $50 million loss in the prior year, driven by strong Pet Health sales and reduced special charges.

Elanco Animal Health's Q1 2025 results show a slight revenue decrease but improved net income, driven by cost management and strategic divestitures.

Elanco Animal Health's Q3 2024 results show a net income of $364 million, driven by a significant gain from the divestiture of its aqua business, despite a slight revenue decrease.

Elanco Animal Health's second-quarter results show a net loss, impacted by restructuring and asset impairments, while revenue saw a modest increase.

Elanco Animal Health's first quarter results show a revenue decrease and a net income decline, influenced by prior year shifts in purchasing patterns and strategic moves including the divestiture of its aqua business.